Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 2.77 USD -10.65% Market Closed
Market Cap: 84m USD

Operating Margin
Skye Bioscience Inc

0%
Current
0%
Average
-7.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-28.2m
/
Revenue
0

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Skye Bioscience Inc
NASDAQ:SKYE
84m USD N/A
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
309.5B USD
28%
US
Amgen Inc
NASDAQ:AMGN
140.9B USD
19%
US
Gilead Sciences Inc
NASDAQ:GILD
112B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.6B USD
40%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
137.8B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
76.7B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
38.5B EUR
-15%

Skye Bioscience Inc
Glance View

Market Cap
84m USD
Industry
Biotechnology

Skye Bioscience, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of cannabinoid-based therapeutics. The company is headquartered in San Diego, California and currently employs 9 full-time employees. The company went IPO on 2014-02-24. The Company’s products programs include THCVHS and CBDVHS. The firm's lead candidate, THCVHS, is a prodrug of tetrahydrocannabinol (THC), is a topical formulation under development for the treatment of glaucoma and ocular hypertension (OHT). The company chemically modifies THC to create a unique synthetic molecule with the intent to realize the known positive effects of THC. Its molecule enables enhanced local delivery in the eye, reduced systemic side effects, and the potential for neuroprotection for the treatment of ocular diseases. CBDVHS is a proprietary analog of cannabidiol (CBD) that has demonstrated biological activity that is both pharmacologically and therapeutically distinct from CBD in various preclinical models.

SKYE Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-28.2m
/
Revenue
0
What is the Operating Margin of Skye Bioscience Inc?

Based on Skye Bioscience Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top